Long- and short-term outcomes for resectable gallbladder carcinoma patients treated with curative-intent laparoscopic versus open resection: a multicenter propensity score-matched comparative study.
Zhi-Peng Liu, Xing-Xing Su, Long-Fei Chen, Xue-Lei Li, Yi-Shi Yang, Zhi-Long You, Xiao-Lin Zhao, Fan Huang, Chao Yu, Zhao-Ping Wu, Wei Chen, Jin-Xue Zhou, Wei Guo, Da-Long Yin, Ping Yue, Rui Ding, Yi Zhu, Wei Chen, Yan Jiang, Jie Bai, Jing-Jing Wang, Yan-Qi Zhang, Dong Zhang, Hai-Su Dai, Wan Yee Lau, Zhi-Yu Chen
{"title":"Long- and short-term outcomes for resectable gallbladder carcinoma patients treated with curative-intent laparoscopic versus open resection: a multicenter propensity score-matched comparative study.","authors":"Zhi-Peng Liu, Xing-Xing Su, Long-Fei Chen, Xue-Lei Li, Yi-Shi Yang, Zhi-Long You, Xiao-Lin Zhao, Fan Huang, Chao Yu, Zhao-Ping Wu, Wei Chen, Jin-Xue Zhou, Wei Guo, Da-Long Yin, Ping Yue, Rui Ding, Yi Zhu, Wei Chen, Yan Jiang, Jie Bai, Jing-Jing Wang, Yan-Qi Zhang, Dong Zhang, Hai-Su Dai, Wan Yee Lau, Zhi-Yu Chen","doi":"10.21037/hbsn-23-518","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Gallbladder cancer (GBC) was once considered a contraindication for laparoscopic surgery, but it is becoming more common to use laparoscopic surgery for GBC treatment. The aim of this study was to analyze the long- and short-term outcomes of patients with more advanced T-staged GBC treated with curative intent as defined by the National Comprehensive Cancer Network (NCCN) after laparoscopic resection (LR) versus open resection (OR).</p><p><strong>Methods: </strong>A multicenter database was used to select consecutive GBC patients treated with curative-intent resection as defined by the NCCN between 2016 and 2020. The patients were divided into the LR group and the OR group. Propensity score matching (PSM) was used to eliminate selection bias. The endpoints were overall survival (OS), progression-free survival (PFS), and short-term outcomes. Risk factors that were independently associated with OS and PFS were identified.</p><p><strong>Results: </strong>Of 626 GBC patients treated with curative-intent resection, after PSM, 51 patients were in the LR group and 153 patients were in the OR group. The LR group had more patients who were suitable to receive adjuvant chemotherapy (AC), a longer operation time, more harvested lymph nodes, and a lower overall morbidity rate. The rates of OS and PFS were not significantly different between the two groups. AC was independently associated with better OS and PFS.</p><p><strong>Conclusions: </strong>The overall morbidity of GBC patients after LR was lower, but the long-term outcomes between LR and OR were not significantly different. The GBC patients treated with LR were more likely to receive AC, and the use of AC after curative-intent resection of GBC helped achieve better long-term survival outcomes.</p>","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"13 5","pages":"788-800"},"PeriodicalIF":6.1000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534770/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatobiliary surgery and nutrition","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/hbsn-23-518","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Gallbladder cancer (GBC) was once considered a contraindication for laparoscopic surgery, but it is becoming more common to use laparoscopic surgery for GBC treatment. The aim of this study was to analyze the long- and short-term outcomes of patients with more advanced T-staged GBC treated with curative intent as defined by the National Comprehensive Cancer Network (NCCN) after laparoscopic resection (LR) versus open resection (OR).
Methods: A multicenter database was used to select consecutive GBC patients treated with curative-intent resection as defined by the NCCN between 2016 and 2020. The patients were divided into the LR group and the OR group. Propensity score matching (PSM) was used to eliminate selection bias. The endpoints were overall survival (OS), progression-free survival (PFS), and short-term outcomes. Risk factors that were independently associated with OS and PFS were identified.
Results: Of 626 GBC patients treated with curative-intent resection, after PSM, 51 patients were in the LR group and 153 patients were in the OR group. The LR group had more patients who were suitable to receive adjuvant chemotherapy (AC), a longer operation time, more harvested lymph nodes, and a lower overall morbidity rate. The rates of OS and PFS were not significantly different between the two groups. AC was independently associated with better OS and PFS.
Conclusions: The overall morbidity of GBC patients after LR was lower, but the long-term outcomes between LR and OR were not significantly different. The GBC patients treated with LR were more likely to receive AC, and the use of AC after curative-intent resection of GBC helped achieve better long-term survival outcomes.
背景:胆囊癌(GBC)曾一度被认为是腹腔镜手术的禁忌症,但使用腹腔镜手术治疗胆囊癌正变得越来越普遍。本研究旨在分析根据美国国立综合癌症网络(NCCN)的定义,晚期T分期GBC患者接受治愈性腹腔镜切除术(LR)与开腹切除术(OR)后的长期和短期疗效:使用多中心数据库选择2016年至2020年间接受NCCN定义的治愈性切除术的连续GBC患者。患者分为LR组和OR组。采用倾向评分匹配法(PSM)消除选择偏倚。研究终点为总生存期(OS)、无进展生存期(PFS)和短期疗效。确定了与OS和PFS独立相关的风险因素:在626名接受治愈性切除术的GBC患者中,经过PSM治疗后,51名患者属于LR组,153名患者属于OR组。LR组中适合接受辅助化疗(AC)的患者更多,手术时间更长,切除的淋巴结更多,总发病率更低。两组患者的 OS 和 PFS 无明显差异。AC与更好的OS和PFS独立相关:结论:LR治疗后,GBC患者的总发病率较低,但LR和OR的远期疗效无明显差异。接受LR治疗的GBC患者更有可能接受AC治疗,GBC根治性切除术后使用AC有助于获得更好的长期生存结果。
期刊介绍:
Hepatobiliary Surgery and Nutrition (HBSN) is a bi-monthly, open-access, peer-reviewed journal (Print ISSN: 2304-3881; Online ISSN: 2304-389X) since December 2012. The journal focuses on hepatopancreatobiliary disease and nutrition, aiming to present new findings and deliver up-to-date, practical information on diagnosis, prevention, and clinical investigations. Areas of interest cover surgical techniques, clinical and basic research, transplantation, therapies, NASH, NAFLD, targeted drugs, gut microbiota, metabolism, cancer immunity, genomics, and nutrition and dietetics. HBSN serves as a valuable resource for professionals seeking insights into diverse aspects of hepatobiliary surgery and nutrition.